AUTL — Autolus Therapeutics Balance Sheet
0.000.00%
- $359.27m
- $15.85m
- $10.12m
- 12
- 22
- 36
- 12
Annual balance sheet for Autolus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 153 | 310 | 382 | 240 | 588 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 29.7 | 26.3 | 29 | 24.5 | 48.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 197 | 347 | 426 | 275 | 661 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 89.7 | 52.3 | 58.4 | 95.7 | 105 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 294 | 406 | 490 | 375 | 783 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 33.6 | 28.6 | 46.4 | 44.7 | 60.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 84.2 | 92.2 | 192 | 264 | 355 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 210 | 313 | 299 | 111 | 427 |
Total Liabilities & Shareholders' Equity | 294 | 406 | 490 | 375 | 783 |